|
1
|
Tai MC, Shui YT, Chang LY and Xue H:
Therapeutic potential of wogonin: A naturally occurring flavonoid.
CNS Drug Rev. 11:141–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang KF, Zhuang Y, Huang YQ and Diao Y:
Experimental study on inhibitory effect of wogonin on proliferation
and invasion of breast cancer cells. Zhongguo Zhong Yao Za Zhi.
39:1485–1489. 2014.(In Chinese). PubMed/NCBI
|
|
3
|
Li XD: Inhibitory effects of wogonin on
lung cancer A549 cell line in vitro. J Chongqing Med Univ.
7:790–793. 2011.(In Chinese).
|
|
4
|
Ding J, Polier G, Köhler R, Giaisi M,
Krammer PH and Li-Weber M: Wogonin and related natural flavones
overcome tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) protein resistance of tumors by down-regulation of c-FLIP
protein and up-regulation of TRAIL receptor 2 expression. J Biol
Chem. 287:641–649. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hong ZP, Wang LG, Wang HJ, Ye WF and Wang
XZ: Wogonin exacerbates the cytotoxic effect of oxaliplatin by
inducing nitrosative stress and autophagy in human gastric cancer
cells. Phytomedicine. 39:168–175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu X, Wu XL, Li Y, Peng Y and Chen PF:
Inhibitory effect of wogonin on gastric cancer SGC 7901 cell line
in vitro. J Chin Pharm Sci. 46:512–517. 2011.
|
|
7
|
Bauman S, Fas SC, Giaisi M, Müller WW,
Merling A, Gülow K, Edler L, Krammer PH and Li-Weber M: Wogonin
preferentially kills malignant lymphocytes and suppresses T-cell
tumor growth by inducing PLCC1 and Ca2+ dependent
apoptosis. Blood. 11:2354–2363. 2008. View Article : Google Scholar
|
|
8
|
Lin CM, Chang H, Chen YH, Wu IH and Chiu
JH: Wogonin inhibits IL6 induced angiogenesis via downregulation of
VEGF and VEGFR-1, not VEGFR-2. Planta Med. 72:1305–1312. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu N, Gao Y, Ling Y, Chen Y, Yang Y, Gu
HY, Qi Q, Liu W, Wang XT, You QD and Guo QL: Wogonin suppresses
tumor growth in vivo and VEGF induced angiogenesis through
inhibiting tyrosine phosphorylation of VEGFR-2. Life Sci.
82:956–963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang HW, Lin CP, Chiu JH, Chow KC, Kuo KT,
Lin CS and Wang LS: Reversal of inflammation as sociated
dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and
drug resistance in nonsmall cell lung cancer cells by wogonin and
chrysin. Int J Cancer. 120:2019–2027. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chow KC, Lu MP and Wu MT: Expression of
dihydrodiol dehydrogenase plays important roles in apoptosis and
drug resistance of A431 squamous cell carcinoma. J Dermatol Sci.
41:205–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Penning TM, Jin Y, Steckelbroeck S,
Lanisnik Rizner T and Lewis M: Structure function of human 3
alpha-hydroxysteroid dehydrogenases: Genes and proteins. Mol Cell
Endocrinol. 215:63–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang HW, Yang Y, Zhang K, Qiang L, Yang
L, Yang L, Hu Y, Wang XT, You QD and Guo QL: Wogonin induced
differentiation and G1 phase arrest of human U-937 leukemia cells
via PKC delta phosphorylation. Eur J Pharmacol. 591:7–12. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho J and Lee HK: Wogonin inhibits
excitotoxic and oxidative neuronal damage in primary cultured rat
cortical cells. Eur J Pharmacol. 485:105–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma SC, Du J, But PP, Deng XL, Zhang YW,
Ooi VE, Xu HX, Lee SH and Lee SF: Antiviral Chinese medicinal herbs
against respiratory syncytial virus. J Ethnopharmacol. 79:205–211.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao WM, Bu P and Gong WJ: Advance in
studies on antitumor and immunomodulatory effects of wogonin.
Zhongguo Zhong Yao Za Zhi. 39:3004–3009. 2014.(In Chinese).
PubMed/NCBI
|
|
17
|
Cantor JR and Sabatini DM: Cancer cell
metabolism: One hallmark, many faces. Cancer Discov. 2:881–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong B and Zhu YM: Molecular-tareted
therapy for cancer. Chin J Cancer. 29:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Batool S, Joseph TP, Hussain M, Vuai MS,
Khinsar KH, Din SRU, Padhiar AA, Zhong M, Ning A, Zhang W, et al:
LP1 from Lentinula edodes C91-3 induces autophagy, apoptosis and
reduces metastasis in human gastric cancer cell line SGC-7901. Int
J Mol Sci. 19(pii): E29862018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park YJ, Lee SR, Kim DM, Yu JS,
Beemelmanns C, Chung KH and Kim KH: The inhibitory effects of
cyclodepsipeptides from the entomopathogenic fungus beauveria
bassiana on myofibroblast differentiation in A549 alveolar
epithelial cells. Molecules. 23(pii): E25682018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Longley DB, Harkin DP and Johnston PG:
5-Fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim EH, Shim B, Kang S, Jeong G, Lee JS,
Yu YB and Chun M: Anti-inflammatory effects of Scutellaria
baicalensis extract via suppression of immune modulators and MAP
kinase signaling molecules. J Ethnopharmacol. 126:320–331. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Zhao X, Zhu D, Liu T, Liang X, Liu
F, Zhang Y, Dong X and Sun B: HIF-1α promoted vasculogenic mimicry
formation in hepatocellular carcinoma through LOXL2 up-regulation
in hypoxic tumor microenvironment. J Exp Clin Cancer Res.
36:602017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shirota Y, Stoehlmacher J, Brabender J,
Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg
PV and Lenz HJ: ERCC1 and thymidy-late synthase mRNA levels predict
survival for colorectal cancer patients receiving combination
oxaliplatin and fluorouracil chemotherapy. J Clin Oncol.
19:4298–4304. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de Gramont A, Figer A, Seymour M, Homerin
M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer
G, et al: Leucovorin and fluorouracil with or without oxaliplatin
as first-line treatment in advanced col-orectal cancer. J Clin
Oncol. 18:2938–2947. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bartrons R and Caro J: Hypoxia, glucose
metabolism and the Warburg's effect. J Bioenerg Biomembr.
39:223–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang BY, Qu QX and Gu AK: Expression and
clinical significance of CD147, MCT4 in cervical lesions. J Int
Obstet Gynecol. 42:194–196. 2015.
|
|
32
|
Pietras A, Johnsson AS and Påhlman S: The
HIF-2α-driven pseudo-hypoxic phenotype in tumor aggressiveness,
differentiation, and vascularization. Curr Top Microbiol Immunol.
345:1–20. 2010.PubMed/NCBI
|
|
33
|
Wolf A, Agnihotri S, Micallef J, Mukherjee
J, Sabha N, Cairns R, Hawkins C and Guha A: Hexokinase 2 is a key
mediator of aerobic glycolysis and promotes tumor growth in human
glioblastoma multiforme. Cell. 208:313–326. 2011.
|
|
34
|
Chen J, Xie J, Jiang Z, Wang B, Wang Y and
Hu X: Shikonin and its analogs inhibit cancer cell glycolysis by
targeting tumor pyruvate kinase-M2. Oncogene. 30:4297–4306. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trufelli DC, Moraes TV, Lima AA and Giglio
AD: Epidemiological profile and prognostic factors in patients with
lung cancer. Rev Assoc Med Bras (1992). 62:428–433. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: Cancers Achilles heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fukumura D, Xu L, Chen Y, Gohongi T, Seed
B and Jain RK: Hypoxia and acidosis independently upregulate
vascular endothelial growth factor transcription in brain tumors in
vivo. Cancer Res. 61:6020–6024. 2001.PubMed/NCBI
|
|
38
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chan AK, Bruce JI and Siriwardena AK:
Glucose metabolic phenotype of pancreatic cancer. World J
Gastroenterol. 22:3471–3485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mansouri S, Shahriari A, Kalantar H, Moini
Zanjani T and Haghi Karamallah M: Role of malate dehydrogenase in
facilitating lactate dehydrogenase to support the glycolysis
pathway in tumors. Biomed Rep. 6:463–467. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ghezzi D, Goffrini P, Uziel G, Horvath R,
Klopstock T, Lochmüller H, D'Adamo P, Gasparini P, Strom TM,
Prokisch H, et al: SDHAF1, encoding a LYR complex-II specific
assembly factor, is mutated in SDH-defective infantile
leukoencephalopathy. Nat Genet. 41:654–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pecsi I, Hards K, Ekanayaka N, Berney M,
Hartman T, Jacobs WR Jr and Cook GM: Essentiality of succinate
dehydrogenase in Mycobacterium smegmatis and its role in the
generation of the membrane potential under hypoxia. MBio. 5(pii):
e01093–14. 2014.PubMed/NCBI
|
|
43
|
Pucino V, Cucchi D and Mauro C: Lactate
transporters as therapeutic targets in cancer and inflammatory
diseases. Expert Opin Ther Targets. 22:735–743. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Han K, Xu X, Chen G, Zeng Y, Zhu J, Du X,
Zhang Z, Cao B, Liu Z and Mao X: Identification of apromising PI3K
inhibitor for the treatment of multiple myeloma throughthe
structural optimization. J Hematol Oncol. 7:92014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wallace DC: Mitochondria and cancer:
Warburg addressed. Cold Spring Harb Symp Quant Biol. 70:363–374.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hudson CC, Liu M, Chiang GG, Otterness DM,
Loomis DC, Kaper F, Giaccia AJ and Abraham RT: Regulation of
hypoxiainducible factor 1alpha expression and function by the
mammalian target of rapamycin. Mol Cell Biol. 22:7004–7014. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Semenza GL: HIF-1: Upstream and downstream
of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
